These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 8963881)

  • 1. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
    Hofmann M; Casper F; Prellwitz W; Brockerhoff P
    Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemostasis and pre-eclampsia].
    Heilmann L; Hojnacki B; Spanuth E
    Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):223-7. PubMed ID: 2055397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of markers of hemostasis activation in obstetrics/gynecology and pediatrics.
    Dati F; Pelzer H; Wagner C
    Semin Thromb Hemost; 1998; 24(5):443-8. PubMed ID: 9834011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation index to distinguish severe preeclampsia from normal pregnancy.
    Kobayashi T; Sumimoto K; Tokunaga N; Sugimura M; Nishiguchi T; Kanayama N; Terao T
    Semin Thromb Hemost; 2002 Dec; 28(6):495-500. PubMed ID: 12536338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
    Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic abnormalities in patients with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic disorders in pregnancy and the peripartum period.
    Hobisch-Hagen P; Mörtl M; Schobersberger W
    Acta Anaesthesiol Scand Suppl; 1997; 111():216-7. PubMed ID: 9421019
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation and fibrinolytic studies in patients with toxemia of pregnancy].
    Okamiya H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1557-64. PubMed ID: 2273312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated intravascular coagulation in pregnancy.
    Smith H; Gregori CA; Breen JL
    J Med Soc N J; 1974 Oct; 71(10):729-36. PubMed ID: 4607971
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombin III levels in pregnancy induced hypertension.
    Ramalakshmi BA; Raju LA; Raman L
    Natl Med J India; 1995; 8(2):61-2. PubMed ID: 7735061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension?
    Caron C; Goudemand J; Marey A; Beague D; Ducroux G; Drouvin F
    Thromb Haemost; 1991 Oct; 66(4):410-4. PubMed ID: 1796389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
    Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
    Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostasis in hypertensive disorders of pregnancy.
    Saleh AA; Bottoms SF; Norman G; Farag A; Mammen EF
    Obstet Gynecol; 1988 May; 71(5):719-22. PubMed ID: 2451798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.